Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End‐Stage Kidney Disease

BACKGROUND: The rate of sudden cardiac death in the hemodialysis population exceeds that of the general population by >20‐fold. Hemodialysis patients may be particularly susceptible to sudden cardiac death provoked by drug‐induced QT prolongation because of their substantial cardiovascular diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Assimon, Magdalene M., Wang, Lily, Pun, Patrick H., Winkelmayer, Wolfgang C., Flythe, Jennifer E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670513/
https://www.ncbi.nlm.nih.gov/pubmed/32578475
http://dx.doi.org/10.1161/JAHA.120.015969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670513/
https://www.ncbi.nlm.nih.gov/pubmed/32578475
http://dx.doi.org/10.1161/JAHA.120.015969

Ejemplares similares